SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-184372
Filing Date
2020-07-01
Accepted
2020-06-30 21:37:31
Documents
7
Period of Report
2020-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d936614d8k.htm 8-K 35718
2 EX-4.1 d936614dex41.htm EX-4.1 91555
3 EX-4.2 d936614dex42.htm EX-4.2 96387
4 EX-5.1 d936614dex51.htm EX-5.1 23223
5 EX-10.1 d936614dex101.htm EX-10.1 203220
6 EX-99.1 d936614dex991.htm EX-99.1 10620
7 GRAPHIC g936614g75c66.jpg GRAPHIC 7726
  Complete submission text file 0001193125-20-184372.txt   472865
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 201003850
SIC: 2834 Pharmaceutical Preparations